Hepatocellular Carcinoma Risk Steadily Persists over Time Despite Long-Term Antiviral Therapy for Hepatitis B: A Multicenter Study.

doi:10.1158/1055-9965.EPI-19-0614

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Community

Back to search

Article

Hepatocellular Carcinoma Risk Steadily Persists over Time Despite Long-Term Antiviral Therapy for Hepatitis B: A Multicenter Study.

Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology - 1 Apr 2020

Kim Seung Up, Seo Yeon Seok, Lee Han Ah, Kim Mi Na, Lee Eun Ju, Shin Hye Jung, Lee Yu Rim, Lee Hye Won, Park Jun Yong, Kim Do Young, Ahn Sang Hoon, Han Kwang-Hyub, Um Soon Ho, Tak Won Young, Kweon Young Oh, Kim Beom Kyung, Park Soo Young

Abstract excerpt

BACKGROUND: Long-term antiviral therapy (AVT) for chronic hepatitis B (CHB) reduces the risk of hepatocellular carcinoma (HCC). We assessed the temporal trends in the incidence of HCC over time during long-term AVT among Asian patients with CHB. METHODS: Patients with CHB receiving entecavir/tenofovir (ETV/TDF) as a first-line antiviral were recruited from four academic hospitals in the Republic of Korea. We...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Carcinoma, Hepatocellular

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Drug Therapy, Combination

Share to Guanine

Share to Hepatitis B, Chronic

Share to Hepatitis B virus

Share to Molecular Typing

Share to Republic of Korea

Share to Tenofovir

Source

Open in PubMed

Identifiers

PMID: 31988073
DOI: 10.1158/1055-9965.EPI-19-0614

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 3 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Hepatocellular Carcinoma Risk Steadily Persists over Time Despite Long-Term Antiviral Therapy for Hepatitis B: A Multicenter Study.PMID 31988073Read ↗

Hepatitis C virus genotype 1b increases cumulative lifetime risk of hepatocellular carcinoma.Semantic proximity Read ↗

Epidemiology and natural history of hepatocellular carcinoma.Semantic proximity Read ↗

Epidemiology of viral hepatitis and hepatocellular carcinoma.Semantic proximity Read ↗

Hepatitis B Virus-Associated Hepatocellular Carcinoma.Semantic proximity Read ↗

Hepatitis E virus infection and risk of hepatocellular carcinoma: A systematic review and meta-analysis.Semantic proximity Read ↗

The risk of early occurrence and recurrence of hepatocellular carcinoma in hepatitis C-infected patients treated with direct-acting antivirals with and without pegylated interferon: A Belgian experience.Semantic proximity Read ↗

The association between hepatic viral infections and cancers: A cross-sectional study in the Taiwan adult populationSemantic proximity Read ↗

Persistent risk for hepatocellular carcinoma after more than a decade of successful hepatitis B virus suppression.Semantic proximity Read ↗

Clinical Efficacy and Post-Treatment Seromarkers Associated with the Risk of Hepatocellular Carcinoma among Chronic Hepatitis C Patients.Semantic proximity Read ↗

Risk of hepatocellular carcinoma development in cases of hepatitis C treated by long-term, low-dose PEG-IFNα-2a.Semantic proximity Read ↗

Higher risk of hepatocellular carcinoma in chronic hepatitis B vs chronic hepatitis C after achievement of virologic response.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.